Urothelial Carcinoma Pathology
On this page
Direct answer
Painless total macroscopic haematuria in an older man is urothelial carcinoma's calling card, and the tumour accounts for over 90% of bladder cancers. Cigarette smoking is the dominant risk factor, with aromatic amines such as beta-naphthylamine in dye, rubber and leather industries close behind. The pathology centres on two questions: grade (papillary urothelial neoplasm of low malignant potential, low-grade, or high-grade, plus flat carcinoma in situ) and depth — invasion of the muscularis propria (detrusor muscle) converts a bladder-preserving disease into one demanding cystectomy with pelvic lymphadenectomy. Because the entire urothelium is field-exposed to the same carcinogens, recurrence at new sites is the rule, making surveillance cystoscopy a lifelong affair.
What you must remember
- Grading (WHO): papillary urothelial neoplasm of low malignant potential, low-grade carcinoma, high-grade carcinoma — architecture plus nuclear atypia; high-grade lesions drive progression.
- Carcinoma in situ: flat, high-grade, denuded urothelium appearing as a red, velvety patch; dangerous — a precursor to invasion; intravesical bacillus Calmette-Guerin is the treatment.
- The muscle question: lamina propria invasion is T1, muscularis propria invasion is T2 — the single most consequential line in the pathology report, and the reason repeat resection is demanded when muscle is absent from the specimen.
- Immunoprofile: GATA3, p63 and high-molecular-weight cytokeratin positive; CK20 normally confined to umbrella cells, and its full-thickness expression marks neoplasia.
- Risk factors: smoking (a large share of cases), aromatic amines, chronic catheterisation and cystitis (squamous carcinoma), cyclophosphamide (both haemorrhagic cystitis and squamous carcinoma), Schistosoma haematobium.
- Schistosoma rule: chronic haematobium infection of the bladder produces squamous cell carcinoma, not urothelial — the classic Egyptian lesion, with egg-laden granulomatous inflammation preceding it.
- Field cancerisation: the whole epithelial surface shares the mutational exposure, hence multifocal tumours, upper tract disease and recurrent appearances over decades.
Painless haematuria, worked through
A 64-year-old smoker passes frank blood at the end of a painless void, then nothing for a week. The pathway is fixed. Urine cytology and computed tomographic urography first — the urogram images the upper tracts, because the same urothelium lines the renal pelvis and ureter, and 5-10% of bladder patients have or will develop upper tract disease. Then cystoscopy: a fronded papillary mass near a ureteric orifice is resected completely (transurethral resection of bladder tumour), and the pathologist reports low-grade papillary urothelial carcinoma confined to the lamina propria with muscle in the specimen — T1, and intravesical therapy plus scheduled cystoscopy follow. Had the report read high-grade with muscle invasion, the conversation changes to neoadjuvant cisplatin chemotherapy and radical cystectomy with urinary diversion. The urothelium's field exposure means the third and fourth tumour are recurrences of the field, not failures of the first resection — which is why patients never leave surveillance.
The muscle question
The most litigated line in genitourinary pathology is "muscle absent". A T1 high-grade tumour in a specimen without detrusor fibres is unstageable — understaging rates are substantial, so a repeat resection within weeks is standard, and early cystectomy is considered for T1 high-grade with variant histology or lymphovascular invasion. The deeper teaching point is embryological: bladder cancer spreads depth-first, and the muscularis propria is both the barrier to the serosa and the boundary between organ-confined and extravesical disease.
Frequently asked questions
What is the most common presenting feature of bladder cancer?
Painless total macroscopic haematuria, prompting urine cytology, CT urography and cystoscopy in sequence.
Why does the pathology report specify the presence of muscularis propria?
Invasion of the detrusor muscle upstages the tumour to T2 and mandates cystectomy with systemic therapy, so a specimen lacking muscle is unstageable and needs re-resection.
Which immunohistochemical markers identify urothelial carcinoma?
GATA3, p63 and high-molecular-weight cytokeratins, with aberrant full-thickness CK20 staining supporting neoplasia.
Which parasite causes squamous carcinoma of the bladder?
Schistosoma haematobium — egg deposition and chronic inflammation drive squamous metaplasia and carcinoma, endemic in the Nile valley.
Why do urothelial tumours recur so often?
The entire urothelial surface is exposed to the same carcinogens (field cancerisation), so new tumours arise at distant sites, mandating long-term cystoscopic surveillance.